| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-06 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |